title: [Therapeutic target for the use of erythropoietin (EPO): is subnormal better than normal?].
authors.affiliation: hanskarle@dadlnet.dk
authors.forename: Hans
authors.initials: H
authors.lastname: Karle
authors.forename: Niels Ebbe
authors.initials: NE
authors.lastname: Hansen
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications; D012307:Risk Factors
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin